top of page

No-Exam Term Life Insurance with Type 1 Diabetes: Why Many Instant Programs Decline

Written by: Jeff Schmidt | Licensed Insurance Broker | CarePro Insurance Content reviewed for accuracy. Not legal, tax, or financial advice.

Many accelerated/no-exam programs use strict medical filters, and type 1 diabetes is commonly outside those filters. That doesn't mean you can't get coverage - it often means a different underwriting path.

  • Instant online pricing

  • No phone calls required

  • No pressure from agents

Type 1 Diabetes Often Doesn't Fit "Instant" Filters

Why accelerated programs screen for certain conditions

What carriers typically evaluate (A1c, complications, stability)

What to do if the instant path says "no"

If you've searched no-exam term life insurance with type 1 diabetes, you've probably already encountered the frustrating part: many instant approval paths don't work for it, and that rejection can feel like a statement about your overall insurability. It isn't. Accelerated programs use strict automated filters to keep decisions fast, and type 1 diabetes -- an autoimmune condition that requires insulin from the time of diagnosis and often presents in childhood or young adulthood -- typically falls outside those filters even when the condition is well managed and stable. The underwriting distinction matters: type 1 is not the same as type 2, and carriers that have developed specific rating tables for type 1 are working from a different actuarial framework than the criteria used for type 2 insulin use or late-onset insulin-dependent diabetes.

Traditional underwriting is often where real options exist. Underwriters look at control and stability over time -- A1c trends across multiple lab draws rather than a single value, complication screening results, and whether there have been recent hospitalizations or significant changes in insulin management. CGM (continuous glucose monitor) data is becoming a more meaningful input at some carriers: time-in-range figures provide a more detailed view of glucose control than a single A1c reading, because they show how often blood sugar stayed within the target range across days and weeks rather than just reflecting the average over a longer period. Some carriers are beginning to incorporate time-in-range alongside A1c as a stability signal, and if you use a CGM, that data may be worth including in any records submitted during the underwriting review.

Hypoglycemic unawareness is a specific concern that underwriters may ask about directly, separately from general diabetes control questions. It refers to the inability to feel early warning symptoms of low blood sugar -- shakiness, sweating, confusion -- which raises accident risk because a severe hypoglycemic episode can occur without the person recognizing the signals in time to self-treat. Carriers ask about it specifically because it carries distinct safety implications beyond standard diabetes management, and a history of hypoglycemic unawareness is evaluated differently from a history of recognized and self-corrected low blood sugar events. Diabetic ketoacidosis (DKA) history is another question that typically surfaces in full underwriting review: a single past DKA episode in a younger patient during an acute illness is evaluated very differently from a pattern of recurrent DKA episodes, which signals ongoing management instability that a detailed records review will need to assess.

The biggest mistake applicants with type 1 diabetes make is treating an instant decline from an accelerated program as the final word on their insurability. In most cases it simply means that specific program's filter cannot accommodate type 1 diabetes -- it is not a conclusion about your overall risk profile or what the broader market will offer. Carriers with structured diabetes review programs, the ability to order labs specific to complication screening, and access to attending physician statements are working with substantially more clinical detail than any quick-filter tool uses. One 'no' from an instant approval screen is a narrow data point about one program's filter design, not a representative view of what life insurance underwriting will conclude about you.

If you want the smoothest path through traditional underwriting, gather your key information before you apply: your most recent A1c value, results from any recent complication screening (kidney function tests, eye exams, cardiovascular evaluation, nerve assessment), a summary of your current insulin regimen or pump settings, and any history of DKA episodes or hypoglycemic unawareness. Organized, complete information helps underwriting move faster because it reduces the number of follow-up requests the carrier needs to generate before reaching a decision -- incomplete applications create delays that accurate preparation avoids entirely.

For a full overview of term life underwriting paths (including when no-exam isn't available), start here: https://www.careproinsurance.com/instant-term-life-insurance

This page provides general education and should not be relied on as legal, medical, or tax advice. Quote-level pricing is directional; the actual cost is set when the policy is issued.

Frequently Asked Questions

Can I get no-exam term life insurance with type 1 diabetes?

Sometimes, but many instant/accelerated programs decline type 1 diabetes. Traditional underwriting may offer more options. Carrier rules vary.

Why do accelerated programs often decline type 1 diabetes?

Accelerated programs use strict filters to keep decisions fast. Type 1 diabetes often falls outside those filters, even when well managed. Exact rules vary by program.

What diabetes details do underwriters care about most?

Common focus areas include A1c trends, stability of management, history of severe hypoglycemia, and complication screening (eyes, kidneys, nerves, heart).

Will I need a medical exam with type 1 diabetes?

Not always, but more detailed underwriting is common. Some carriers may require records or additional information depending on coverage amount and history.

Does an instant decline mean I can't get term life coverage?

Not necessarily. It often means that specific accelerated track won't offer coverage. Other carriers or traditional underwriting may still be possible depending on your profile.

How is type 1 diabetes underwritten differently from type 2 diabetes?

Type 1 is an autoimmune condition requiring insulin from diagnosis, often presenting earlier in life. Type 2 is typically associated with insulin resistance and often develops in adulthood. Carriers apply different actuarial tables to each, and a carrier with a type 2 insulin program may not have equivalent guidelines for type 1. The underlying disease mechanism, age of onset, and complication trajectory differ in ways that produce different underwriting outcomes.

Can CGM time-in-range data help my life insurance underwriting outcome?

It may, at carriers that have begun incorporating CGM data into their review process. Time-in-range figures show how often blood sugar stayed within target range across an extended period, providing a more nuanced view of control than a single A1c reading. If you use a CGM, asking your care provider to include a time-in-range summary in any submitted records may be a useful step during traditional underwriting.

What is hypoglycemic unawareness, and why do underwriters ask about it separately from general diabetes questions?

Hypoglycemic unawareness is the inability to feel early warning symptoms of low blood sugar, which raises accident risk because severe episodes can occur without the person recognizing them in time to self-treat. It carries distinct safety implications beyond standard diabetes management questions, so underwriters ask about it separately. A history of hypoglycemic unawareness is evaluated differently from a history of recognized and self-corrected hypoglycemic episodes.

bottom of page